TANANBAUM JAMES B. reported 3 transactions at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/5/2024ACC: 0001415889-24-010434
Director10% Owner
Since Dec 2020
-13.78M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
13.78M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−9.67M
Price / share
—
Trade value
—
% of position
New position
4/3/2024
9.67M→0.00
Common Stock
Indirect
Shares
−3.53M
Price / share
—
Trade value
—
% of position
New position
4/3/2024
3.53M→0.00
Common Stock
Indirect
Shares
−520.71K
Price / share
—
Trade value
—
% of position
New position
4/3/2024
520.71K→0.00
Total
Net shares
−13.72M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/3/2024 | D · Disposition | −9.67M | — | — | New position | 9.67M | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −3.53M | — | — | New position | 3.53M | 0.00 |
| Common Stock Indirect | 4/3/2024 | D · Disposition | −520.71K | — | — | New position | 520.71K | 0.00 |
| Total | −13.72M | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
40.50K shares
Shares
−40.50K
Strike price
20
Held after
0.00
Exercisable
—
4/3/2024
Stock Option (right to buy)
Direct
Converts to
Common Stock
20.25K shares
Shares
−20.25K
Strike price
8.38
Held after
0.00
Exercisable
—
4/3/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock40.50K shares | 4/3/2024 | D · Disposition | −40.50K | 20 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock20.25K shares | 4/3/2024 | D · Disposition | −20.25K | 8.38 | — | 0.00 |